爱朋医疗 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	404.0M	422.0M	324.0M	461.0M	443.0M
Revenue Growth %	-4.3%	30.2%	-29.7%	4.1%	--
Total Revenue	404.0M	422.0M	324.0M	461.0M	443.0M
Cost Of Revenue	128.0M	145.0M	164.0M	166.0M	189.0M
+Gross Profit	276.0M	277.0M	160.0M	295.0M	254.0M
Gross Margin %	68.3%	65.6%	49.4%	64.0%	57.3%
Total Operating Cost	405.0M	424.0M	427.0M	419.0M	349.0M
Selling Expenses	154.0M	148.0M	143.0M	126.0M	91.4M
Admin Expenses	77.6M	80.9M	64.6M	73.4M	46.1M
Rd Expenses	33.3M	36.5M	34.9M	44.0M	23.6M
Finance Expenses	1.1M	825,500	452,100	-2.4M	-7.2M
+Operating Income	23.5M	14.0M	-88.3M	55.8M	114.0M
Operating Margin %	5.8%	3.3%	-27.3%	12.1%	25.7%
Non Operating Income	300.00	180,800	142,500	168,000	14,300
Non Operating Expenses	2.3M	338,500	2.5M	655,200	1.6M
Investment Income	-1.4M	-1.4M	1.4M	857,100	1.3M
Asset Disposal Income	3.6M	6,700	-20,100	--	--
Asset Impairment Loss	585,200	470,700	16.4M	87,000	--
Other Income	22.4M	17.0M	13.8M	12.4M	18.3M
Income Before Tax	21.2M	13.8M	-90.7M	55.3M	112.0M
Income Tax	10.3M	5.4M	-14.6M	2.0M	15.0M
+Net Income	10.9M	8.5M	-76.1M	53.3M	96.9M
Net Margin %	2.7%	2.0%	-23.5%	11.6%	21.9%
Net Income Attributable	10.8M	8.3M	-76.0M	54.1M	97.0M
Minority Interest	94,100	172,700	-135,700	-745,300	-87,100
Eps Basic	0.09	0.07	-0.60	0.43	0.77
Eps Diluted	0.09	0.07	-0.60	0.43	0.77

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	202.0M	201.0M	249.0M	275.0M	389.0M
Trading Financial Assets	1.0M	1.0M	--	--	--
Accounts Receivable	157.0M	148.0M	111.0M	121.0M	79.2M
Notes Receivable	2.4M	2.6M	1.6M	1.6M	6.5M
Notes And Accounts Receivable	159.0M	151.0M	112.0M	122.0M	85.7M
Prepayments	19.2M	12.9M	9.8M	8.2M	8.7M
Inventory	62.7M	55.7M	61.0M	67.4M	31.7M
Total Current Assets	458.0M	442.0M	445.0M	484.0M	523.0M
Long Term Equity Investment	52.4M	47.0M	50.1M	48.4M	38.0M
Fixed Assets	--	126.0M	133.0M	102.0M	56.9M
Fixed Assets Total	154.0M	126.0M	133.0M	102.0M	56.9M
Construction In Progress	--	54.0M	37.4M	70.5M	112.0M
Construction In Progress Total	20.3M	54.0M	37.4M	70.5M	112.0M
Intangible Assets	36.3M	34.0M	35.6M	33.2M	37.7M
Long Term Deferred Expenses	12.8M	18.7M	22.7M	7.6M	1.5M
Total Non Current Assets	405.0M	417.0M	425.0M	415.0M	304.0M
Total Assets	863.0M	860.0M	871.0M	899.0M	827.0M
Short Term Borrowings	48.4M	39.2M	29.4M	--	--
Accounts Payable	21.8M	28.9M	45.2M	25.8M	31.4M
Advance Receipts	--	--	--	--	--
Contract Liabilities	16.2M	16.0M	30.7M	4.5M	3.4M
Total Current Liabilities	126.0M	130.0M	147.0M	76.6M	85.2M
Total Non Current Liabilities	30.0M	32.5M	36.9M	42.0M	2.2M
Total Liabilities	156.0M	162.0M	184.0M	119.0M	87.4M
Paid In Capital	126.0M	126.0M	126.0M	126.0M	105.0M
Capital Reserve	331.0M	330.0M	330.0M	348.0M	351.0M
Surplus Reserve	52.8M	43.3M	41.5M	41.5M	36.5M
Retained Earnings	190.0M	197.0M	188.0M	264.0M	247.0M
Minority Equity	8.2M	992,300	819,600	902,500	320,200
Equity Attributable	700.0M	696.0M	686.0M	780.0M	740.0M
Total Equity	708.0M	697.0M	687.0M	781.0M	740.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	437.0M	383.0M	403.0M	490.0M	473.0M
Tax Refunds Received	16.8M	11.1M	7.3M	7.9M	9.6M
Total Operating Cash Inflow	465.0M	403.0M	425.0M	508.0M	502.0M
Cash Paid For Goods	152.0M	142.0M	174.0M	206.0M	195.0M
Cash Paid To Employees	125.0M	125.0M	136.0M	125.0M	92.2M
Taxes Paid	45.4M	33.6M	28.0M	52.3M	47.6M
Total Operating Cash Outflow	449.0M	426.0M	449.0M	490.0M	419.0M
Operating Cash Flow	15.7M	-23.3M	-24.6M	18.3M	83.3M
Total Investing Cash Inflow	100.0M	178.0M	261.0M	369.0M	431.0M
Total Investing Cash Outflow	108.0M	204.0M	286.0M	465.0M	514.0M
Investing Cash Flow	-8.0M	-26.2M	-24.8M	-96.7M	-83.1M
Cash From Borrowings	48.4M	49.1M	29.4M	--	--
Dividends And Interest Paid	9.6M	1.3M	633,600	31.5M	32.3M
Debt Repayments	39.2M	39.3M	--	--	448,000
Total Financing Cash Inflow	48.5M	49.1M	29.4M	50,000	448,000
Total Financing Cash Outflow	55.5M	47.4M	5.5M	35.9M	32.8M
Financing Cash Flow	-7.0M	1.7M	23.9M	-35.8M	-32.3M
Net Change In Cash	738,900	-47.9M	-25.5M	-114.0M	-32.0M
Ending Cash Balance	202.0M	201.0M	249.0M	274.0M	389.0M
Capex	10.2M	30.7M	24.2M	39.6M	35.6M